3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
26
Breast Neoplasms
5
Leiomyoma
3
Neoplasms
2
Sleep Wake Disorders
1
Sarcopenia
1
Prostatectomy
1
Polycystic Ovary Syndrome
1
Pelvic Pain
1
Osteoporosis
1
Neoplasm Metastasis
1
Kallmann Syndrome
1
Hypogonadism
1
Hyperprolactinemia
1
Highly Endocrine Responsive Operable Breast Cancer
1
Hemorrhage
1
Fatigue
1
Endometriosis
1
Cardiovascular Diseases
1
Breast Neoplasms, Male
1
Advanced Prostate Cancer
1
Adenomyosis
1
Interventions
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Goserelin
1
Gonadotropin-Releasing Hormone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Advanced Prostate Cancer
×
Gonadotropin-Releasing Hormone
×
Clear all
NCT02234089
2019-07-05
ProComD
Ferring Pharmaceuticals
Completed
461 enrolled